Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. Its product candidates include ANX005, a monoclonal antibody, which is in Phase II/III clinical trials to treat patients with guillain-baré syndrome. The company was incorporated in 2011 and is headquartered in Brisbane, California.
Market Cap | 182.424 Million | Shares Outstanding | 47.63 Million | Avg 30-day Volume | 572.292 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -0.96 |
Price to Revenue | 0.0 | Debt to Equity | 0.0 | EBITDA | -127.319 Million |
Price to Book Value | 1.8984 | Operating Margin | 0.0 | Enterprise Value | 197.539 Million |
Current Ratio | 11.391 | EPS Growth | 0.181 | Quick Ratio | 11.162 |
1 Yr BETA | 0.9494 | 52-week High/Low | 7.65 / 2.06 | Profit Margin | 0.0 |
Operating Cash Flow Growth | -99.8794 | Altman Z-Score | 2.788 | Free Cash Flow to Firm | -87.621 Million |
Earnings Report | 2023-05-08 |
Please sign in first
2.6 Million total shares from 1 transactions
10.1 Thousand total shares from 5 transactions
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
LEW JENNIFER EVP & CHIEF FINANCIAL OFFICER |
|
48,517 | 2023-02-16 | 3 |
LOVE DOUGLAS PRESIDENT & CEO |
|
0 | 2023-02-16 | 6 |
OVERDORF MICHAEL EVP & CHIEF BUSINESS OFFICER |
|
46,780 | 2023-02-16 | 3 |
|
7,056,024 | 2023-02-10 | 3 | |
ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER |
|
210,000 | 2023-01-15 | 2 |
MATTHEAKIS LARRY EVP & CHIEF SCIENTIFIC OFFICER |
|
54,688 | 2022-07-11 | 2 |
|
24,000 | 2022-06-09 | 1 | |
|
24,000 | 2022-06-09 | 1 | |
|
24,000 | 2022-06-09 | 1 | |
|
24,000 | 2022-06-09 | 1 | |
|
24,000 | 2022-06-09 | 1 | |
KESWANI SANJAY EVP & CHIEF MEDICAL OFFICER |
|
112,500 | 2022-02-11 | 0 |
YEDNOCK TED EVP & CHIEF SCIENTIFIC OFFICER |
|
78,554 | 2021-09-13 | 0 |
|
10,000 | 2021-06-02 | 0 | |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) |
|
No longer subject to file | 2020-07-28 | 0 |
BLACKSTONE HOLDINGS I/II GP L.L.C. |
|
No longer subject to file | 2020-07-28 | 0 |
|
No longer subject to file | 2020-07-28 | 0 | |
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC BAIN CAPITAL LIFE SCIENCES FUND, L.P. BCIP LIFE SCIENCES ASSOCIATES, LP |
|
No longer subject to file | 2020-07-28 | 0 |
|
0 | 2020-07-23 | 0 | |
|
0 | 2020-07-23 | 0 | |
|
0 | 2020-07-23 | 0 | |
|
0 | 2020-07-23 | 0 | |
|
0 | 2020-07-23 | 0 | |
|
0 | 2020-07-23 | 0 | |
|
0 | 2020-07-23 | 0 | |
|
0 | 2020-07-23 | 0 | |
|
0 | 2020-07-23 | 0 | |
|
0 | 2020-07-23 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-02-21 17:28:32 -0500 | 2023-02-16 | A | 345,000 | a | 345,000 | direct | ||||||||||
2023-02-21 17:27:06 -0500 | 2023-02-16 | A | 18,975 | a | 46,780 | direct | -1.5483 | -6.9217 | 0.0 | 1 | -6.9217 | 6 | ||||
2023-02-21 17:27:06 -0500 | 2023-02-16 | A | 77,050 | a | 77,050 | direct | ||||||||||
2023-02-21 17:26:07 -0500 | 2023-02-16 | A | 18,975 | a | 48,517 | direct | -1.5483 | -6.9217 | 0.0 | 1 | -6.9217 | 6 | ||||
2023-02-21 17:26:07 -0500 | 2023-02-16 | A | 77,050 | a | 77,050 | direct | ||||||||||
2023-02-17 17:12:31 -0500 | 2023-02-15 | S | 6,571 | $5.87 | d | 197,646 | direct | -4.3554 | -7.1429 | 0.0 | 1 | -7.1429 | 6 | |||
2023-02-15 19:00:45 -0500 | 2023-02-14 | S | 144 | $6.30 | d | 27,805 | direct | 0.1684 | -9.2593 | 0.1684 | 2 | -9.2593 | 6 | |||
2023-02-15 18:59:57 -0500 | 2023-02-14 | S | 166 | $6.30 | d | 29,542 | direct | 0.1684 | -9.2593 | 0.1684 | 2 | -9.2593 | 6 | |||
2023-02-15 19:00:45 -0500 | 2023-02-13 | S | 1,501 | $6.30 | d | 27,949 | direct | 0.1684 | -9.2593 | 0.1684 | 2 | -9.2593 | 6 | |||
2023-02-15 18:59:57 -0500 | 2023-02-13 | S | 1,742 | $6.31 | d | 29,708 | direct | 0.1684 | -9.2593 | 0.1684 | 2 | -9.2593 | 6 | |||
SATTER MUNEER A - Director - > 10% Owner see footnote |
2023-02-14 16:31:56 -0500 | 2023-02-10 | P | 2,647,058 | $6.80 | a | 7,056,024 | indirect | 0.678 | -8.3898 | 0.8475 | 3 | -8.3898 | 6 |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
ANNEXON INC ANNX | 2023-03-24 22:15:03 UTC | 3.9586 | 0.8614 | 350000 |
ANNEXON INC ANNX | 2023-03-24 21:45:03 UTC | 3.9586 | 0.8614 | 350000 |
ANNEXON INC ANNX | 2023-03-24 21:15:03 UTC | 3.9586 | 0.8614 | 350000 |
ANNEXON INC ANNX | 2023-03-24 20:45:03 UTC | 3.9586 | 0.8614 | 350000 |
ANNEXON INC ANNX | 2023-03-24 20:15:04 UTC | 3.9586 | 0.8614 | 350000 |
ANNEXON INC ANNX | 2023-03-24 19:45:03 UTC | 3.9586 | 0.8614 | 350000 |
ANNEXON INC ANNX | 2023-03-24 19:15:04 UTC | 3.9586 | 0.8614 | 350000 |
ANNEXON INC ANNX | 2023-03-24 18:45:04 UTC | 3.968 | 0.852 | 350000 |
ANNEXON INC ANNX | 2023-03-24 18:15:03 UTC | 3.968 | 0.852 | 350000 |
ANNEXON INC ANNX | 2023-03-24 17:45:03 UTC | 3.968 | 0.852 | 350000 |
ANNEXON INC ANNX | 2023-03-24 17:15:03 UTC | 3.968 | 0.852 | 350000 |
ANNEXON INC ANNX | 2023-03-24 16:45:03 UTC | 3.968 | 0.852 | 350000 |
ANNEXON INC ANNX | 2023-03-24 16:15:03 UTC | 3.968 | 0.852 | 200000 |
ANNEXON INC ANNX | 2023-03-24 15:45:03 UTC | 3.968 | 0.852 | 200000 |
ANNEXON INC ANNX | 2023-03-24 15:15:03 UTC | 3.968 | 0.852 | 300000 |
ANNEXON INC ANNX | 2023-03-24 14:45:03 UTC | 3.968 | 0.852 | 300000 |
ANNEXON INC ANNX | 2023-03-24 14:15:03 UTC | 3.968 | 0.852 | 150000 |
ANNEXON INC ANNX | 2023-03-24 13:45:03 UTC | 4.0496 | 0.5204 | 150000 |
ANNEXON INC ANNX | 2023-03-24 13:15:04 UTC | 4.0496 | 0.5204 | 150000 |
ANNEXON INC ANNX | 2023-03-24 12:45:03 UTC | 4.0496 | 0.5204 | 150000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|